Key Insights

Highlights

Treatment Research

13 treatments under study, led by Radiation Therapy

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Withdrawn1

Clinical Trials (1)

Showing 1 of 1 trials
NCT00310128Phase 2Withdrawn

Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma

Showing all 1 trials

Research Network

Common Treatments

  • Radiation Therapy1
  • Radioimmunotherapy1
  • Rituximab1
  • Etoposide1
  • Biological Therapy1

Active Sponsors

  • National Cancer Institute (NCI)1
  • AIDS Malignancy Consortium1

Top Investigators

Related Conditions

  • Aidsrelated Lymphoma1
  • Anaplastic Large Cell Lymphoma1

Activity Timeline